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While a wealth of literature describes the short and longer term impact of living with epilepsy, there is, in contrast, very little
information about the impact of psychologically derived non-epileptic attack disorder (PNEAD). In the absence of any physical
disease, some clinicians may assume that this group requires little help. However, evidence suggests that there maybe a significant
impact. Therefore, this study has set out to document the effects on perceived health status of PNEAD.
We compared 97 people with PNEAD with a sample, case matched for age and gender, of 97 people who had been previously
diagnosed with epilepsy. A questionnaire was administered to both groups requesting information about their perceived overall
health (SF-36) and their clinical and demographic status.
PNEAD patients described a significantly poorer profile of perceived health compared with the epilepsy group. People with
PNEAD have substantially impaired perceived health status, to the extent of feeling in poorer health than people with organically
explained epilepsy. Clinical interventions are necessary that can improve their perceived health.
© 2003 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
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INTRODUCTION
Psychologically derived non-epileptic attack disorder
(PNEAD) is increasingly recognised as a signifi-
cant clinical problem1. A failure to identify those
with PNEAD can lead to a number of risks for
such patients, including: polypharmacy and anti-
convulsant toxicity, hazardous interventions, signif-
icant social and economic demands and a failure
to treat the underlying cause appropriately2. PNEAD
has been linked with a number of possible expla-
nations, including borderline and multiple person-
ality disorder, post-traumatic stress disorder and
Munchausen’s Syndrome3. Alternatively, Ford4
argues that PNEAD is strongly associated with somati-
sation, defined as the expression of emotional discom-
fort and psychosocial stress in the language of bodily
symptoms5.
Since patients with PNEAD have no physical
pathology, it might be expected that their symptoma-
tology and the wider impact of their disorder on their
lives should be less than in patients with confirmed
epilepsy. However, paradoxically, there is evidence
that patients with persistent medically unexplained
symptoms are, in fact, more impaired than patients
with chronic and disabling medical conditions6.
Moreover, the incidence of psychological trauma is
greater in patients with PNEAD and other unex-
plained symptoms than in patients with epilepsy or
other organic conditions7, and such trauma is likely
to increase physical and emotional morbidity8. In a
preliminary comparison, the authors have found that
patients with PNEAD were, indeed, more distressed
than patients with epilepsy on a range of psychologi-
cal measures9. Another report suggested that patients
with PNEAD report more limitations in their physical
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health than patients with epilepsy10. However, the
samples were relatively small (n = 62 and 50) and in
only one of the studies9 were they matched for gender
or age. Therefore, the present study compared large,
matched groups of patients with PNEAD and epilepsy
across a range of measures of perceived health sta-
tus. The authors predicted that, in the present study,
PNEAD patients would be more impaired than age-
and gender-matched patients with epilepsy in both
physical and psychological functioning. The findings
of this study will therefore help to understand the
wider impact of PNEAD.
MATERIALS AND METHODS
Patient selection
Patients attending the Walton Centre for Neurology
and Neurosurgery, Liverpool, for the assessment or
treatment of PNEAD were invited to participate in the
study. Patients with PNEAD were matched in terms
of age and gender with patients with epilepsy. Patients
with PNEAD were recruited via a specific clinic for
people with PNEAD led by one of the authors (G.B.),
to which they were referred from the neuropsycho-
logical outpatients clinics. Patients with epilepsy were
recruited via the epilepsy outpatient clinics at the Wal-
ton Centre for Neurology and Neurosurgery. All pa-
tients with epilepsy or PNEAD were diagnosed by an
experienced epileptologist on the basis of electroen-
cephalographic results, video telemetry, clinical ob-
servations and psychological/psychiatric histories or a
combination thereof.
One hundred and thirty patients were initially re-
cruited on the basis of the diagnosis of PNEAD made
between 12 and 36 months previously. They were ex-
cluded from the study if they were also diagnosed with
epilepsy (n = 18), were learning disabled (n = 6), or
felt too unwell/or upset to complete the self-completed
questionnaire (n = 1). Of the patients who met the
inclusion criteria, two patients refused to fill out the
questionnaire because they had no time (n = 2), or
without stating a reason. Six patients started the ques-
tionnaire but failed to complete it and were therefore
discarded. Ninety-seven patients with PNEAD were
therefore included in the study.
One hundred and fifty-three patients, with epilepsy
diagnosed by a Consultant Neurologist in the previous
12–36 months period, were initially identified to form
an age and matched comparative group. Patients with
epilepsy were excluded if they were learning disabled
(n = 7), or too distressed to participate (n = 14). A
number of patients with epilepsy refused to complete
the study questionnaire, stating that they had insuffi-
cient time (n = 20). Sixteen patients did not provide a
reason for not participating. Responses were discarded
for15 people who started the questionnaire but failed to
complete it. Ninety-seven patients with epilepsy were
age and sex matched with the PNEAD sample.
Data collection
Each participant completed a battery of question-
naires, including the Short-Form-36 Health Survey
(SF-36)11, and other questionnaires not reported here.
Information was also collected in respect of clinical
and demographic details.
The Short-Form-36 Health Survey (SF-36)
The SF-36 was designed as a generic indicator of
health status for use in evaluative studies of health
policy. The SF-36 can be used as an outcome measure
in clinical research and practice. The SF-36 measures
both physical and psychological health. The SF-36
includes multi-item scales to measure eight dimen-
sions (Physical Functioning, General Health, Bodily
Pain, Fatigue, Mental Health, Social Functioning,
Role Physical, Role Emotional Limitations). It is
self-administered and takes 5–10 minutes to complete.
Scoring transforms the answers of each question into
scaled scores from 0 to 100 so that high values rep-
resent more favourable physical and psychological
states11.
Statistical analyses
Data were analysed using the statistical package for
social sciences (SPSS 10.0). Student’s t tests and
Chi-square were used to examine the differences be-
tween groups in scores on the SF-36 and clinical and
demographic features, including education, religion
and employment status.
RESULTS
Details of the samples are summarised in Table 1.
There were 97 patients in each of the PNEAD and
epilepsy groups, who were of similar age (mean =
34); in both groups the number of female patients was
greater than male (69/97 vs. 28/97 in each group).
There were no statistical differences in marital status
and religion. The number of PNEAD patients with one
or more educational qualifications was lower than for
the patients with epilepsy.
There were significant differences between the two
groups on a number of clinical variables, with PNEAD
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Table 1: Demographic characteristics of the PNEAD and
epilepsy groups.
PNEAD Epilepsy
(n = 97) (n = 97)
Marital status
Single 37 39
Divorced/widowed 22 15
Married/living with partner 38 43
Employment
Unemployed 22 19
Employed 24 32
Self-employed 34 28
Not seeking employment 17 18
Type of employment*
Unemployed 69 65
Unskilled/shop work 15 25
Skilled 7 1
Professional 6 6
Education**
One or more formal qualifications 58 75
* P < 0.05.
** P < 0.01.
patients more likely to report long-term health prob-
lems (χ2 = 4.73, P < 0.05), less likely to be taking
antiepileptic medication (χ2 = 69.37, P < 0.001),
and less likely to report partial seizures (χ2 = 7.68,
P < 0.05) but more likely to report more frequent
seizures (see Table 2).
A comparison on the SF-36 revealed significant dif-
ferences on several domains between the PNEAD and
epilepsy patients. People with PNEAD reported worse
scores than people with epilepsy on the Role Emo-
tional (P < 0.01), Mental Health (P < 0.01), Gen-
eral Health (P = 0.008), Role Physical (P < 0.01),
Bodily Pain (P < 0.001) and Fatigue (P < 0.001) do-
mains. No significant differences were found between
diagnostic groups for Physical or Social Functioning
(Table 3).
Table 2: Clinical characteristics of the PNEAD and epilepsy
groups.
PNEAD Epilepsy
Features of attacks
Generalised seizures 48 55
Absence seizures 34 42
Attacks with trance-like status* 22 40
Attacks of falling with brief loss
of consciousness
31 35
Brief jerks of the body or arms 27 33
Seizure frequency*
None in past year 5 22
Less than one a month 29 33
One or more a month 63 42
Receiving AED treatment* 20 78
Long-term health problems* 37 23
* P < 0.05.
Table 3: Mean scores on the SF-36 for the PNEAD and
epilepsy groups.
Domain PNEAD Epilepsy
Role Emotional* 39.3 50.0
Mental Health* 26.0 55.6
General Health* 40.9 54.3
Physical Functioning 59.7 66.6
Social Functioning 56.8 61.3
Role Physical* 31.9 45.7
Bodily Pain** 49.1 68.6
Fatigue** 23.3 50.3
* P < 0.01.
** P < 0.001.
Fig. 1 displays the SF-36 profile for the two groups
and for a sample of people with long-standing health
problems12.
DISCUSSION
This study is unique in that it compared the subjective
health complaints of patients with intractable epilepsy
with patients with PNEAD matched for age and sex,
in a relatively large cohort. Similarly to the previous
but smaller study by Breier et al.10, all but five pa-
tients with epilepsy in this study were experiencing
uncontrolled seizures. All patients with either epilepsy
or PNEAD had their diagnosis confirmed by epilep-
tologists in a specialised epilepsy centre.
The PNEAD group was similar to the epilepsy group
on a number of clinical and demographic variables
although they were more likely to be in skilled em-
ployment but less likely to possess educational qual-
ifications than the patients with epilepsy. In terms of
the clinical characteristics of reported seizures, the
PNEAD group was less likely to report partial seizures
but more likely to report frequent seizures than pa-
tients with epilepsy.
Patients with PNEAD in this study reported a sig-
nificantly poorer quality of life than patients with
epilepsy as measured by the SF-36. The findings from
the epilepsy group were typical of findings from pre-
viously published studies, which showed that people
with epilepsy reported impairment in physical, social
and psychological well-being9. Interestingly, both
groups reported health problems across the range
of domains, with the PNEAD group reporting more
significant difficulties for emotional role functioning,
mental health functioning, general health functioning,
physical role functioning, bodily pain and fatigue than
the patients with epilepsy. In addition, the patients in
the PNEAD group were more likely to report long-
term health problems than the patients with epilepsy.
These results suggest that people with PNEAD
experience their lives as more disabling than people
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Fig. 1: Comparison of mean scores for the SF-36 health status measure: for people with epilepsy, PNEAD and UK general
population with long-standing illness.
with chronic epilepsy arising from serious physical
pathology. While the PNEAD group does not experi-
ence the significant physical, social and psychological
sequealae associated with resistant epilepsy13, 14, they
do face difficult challenges that are likely to be as-
sociated with their childhood and family experiences
(psychological, physical or sexual abuse)15–21. The
importance of this research is the recognition that this
group of patients present with multifaceted physical
and psychological problems that warrant substantial
clinical intervention, from a multidisciplinary team
with experience in managing this condition.
We consider that there are two hypotheses that could
explain why people with PNEAD report significantly
more health problems than people with epilepsy: Re-
duced scores on the SF-36 in the PNEAD sample may
be a reflection of their emotional distress expressed as
physical health concerns. Alternatively, people with
PNEAD, may in the absence of any physical pathol-
ogy, exaggerate their poor health status in order to jus-
tify their level of disability. Testing these hypotheses
should be the focus for future research.
There are a number of limitations to this study that
may affect the generalisability of the results and these
include the following: The epilepsy group was biased
towards people with more problematic epilepsy char-
acterised by high seizure frequency and by the greater
number of people who refused to participate because
they were distressed. The reliance on the use of
self-reported measures to assess perceived health sta-
tus, that may not reflect actual behaviour. Psychiatric
measures were not used to assess the potential influ-
ence of psychiatric conditions on self-reported health
status. However, the SF-36 has been used widely and
is regarded as a valid and reliable measure of per-
ceived health status. Therefore, accepting these limita-
tions, the results highlight the perceived wide-ranging
level of disability in patients with PNEAD.
In conclusion, this study has shown that, by com-
parison with patients with resistant epilepsy, patients
with PNEAD reported a significantly worse health
status and long-term health problems. This was de-
spite the fact that they had all been diagnosed with
PNEAD and only relatively small proportions were
taking antiepileptic medication. These results high-
light the challenge that clinicians must face when
managing people with this condition and the ben-
efits from understanding the wider impact of the
condition for both physical and psychological func-
tioning. Further research and clinical intervention
is warranted to understand what factors are impor-
tant in the development and maintenance of this
condition and what interventions may ameliorate its
impact.
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